Facebook page "JSP Pharma - JP สุภาพโอสถ70ปี" impersonates "JSP Pharmaceutical Manufacturing (Thailand) Plc." : Unlicensed securities and derivatives business (Disclosure Date : 05/03/2025)
decelerating rate due to slowdown in external sector and manufacturing production at home. Meanwhile, private consumption which continued to expand was derived mainly from increased expenditures on automobiles
business strategies for the first quarter of 2018, KBank and subsidiaries thus reported Baht 10,766 million in net profit, increasing Baht 595 million or 5.84 percent over the same period of last year. The
28.6% when compared to the third quarter of 2017. Almost of net non-interest income are dividend income, which came from increasing investments - net by 2.6%. Other Operating Expenses In the third
around the globe turned cautious as investors resorted to increasing their holdings of safe-haven assets, prompting Thai and US bond yields to drop across all maturities. The Federal Reserve was thus
%, followed by manufacturing and commerce sector at 21.1% and housing loans sector at 19.6% of total loans. Big Corporate & Corporate As of 30 June 2017, the bank had total loans to customers of Big Corporate
million in net profit, increasing Baht 151 million or 1.40 percent over-quarter. The increase came from net interest income, which rose Baht 671 million, or 2.83 percent. Net interest margin (NIM) was equal
the banking sector in the year 2018, overall commercial bank loan expanded in line with the economic growth. Consumer loan expanded increasing, while corporate loan grew in several businesses